PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties Grant US-11932675-B2 United States of America 19 Mar 2024
Altering microbial populations and modifying microbiota Grant US-11844760-B2 United States of America 19 Dec 2023
Treating and preventing microbial infections Grant US-11788085-B2 United States of America 17 Oct 2023
Reducing tumor burden by administering CCR1 antagonists in combination with PD-1… Grant US-11744822-B2 United States of America 05 Sep 2023
REDUCING TUMOR BURDEN BY ADMINISTERING CCR1 ANTAGONISTS IN COMBINATION WITH PD-1… N/A TW-I808938-B Chinese Taipei 21 Jul 2023
Interleukin-2 fusion proteins and uses thereof Grant US-11680090-B2 United States of America 20 Jun 2023
Combination therapies for treating cancer with niraparib and PD-1 inhibitors Grant US-11661453-B2 United States of America 30 May 2023
Treating and preventing microbial infections Grant US-11643653-B2 United States of America 09 May 2023
Altering microbial populations and modifying microbiota Grant US-11642363-B2 United States of America 09 May 2023
Altering microbial populations and modifying microbiota Grant US-11612617-B2 United States of America 28 Mar 2023
ANTI-PD-1 AND PD-L1 TETRAVALENT BISPECIFIC ANTIBODY Application EP-3964530-A4 European Patent Office 18 Jan 2023
Altering microbial populations and modifying microbiota Grant US-11547716-B2 United States of America 10 Jan 2023
IL-2 superagonists in combination with anti-PD-1 antibodies Grant US-11542312-B2 United States of America 03 Jan 2023
Compositions and methods for immune-mediated cancer therapy Grant US-11534445-B2 United States of America 27 Dec 2022
Altering microbial populations and modifying microbiota Grant US-11517582-B2 United States of America 06 Dec 2022
Treating and preventing microbial infections Grant US-11485973-B2 United States of America 01 Nov 2022
Selectively altering microbiota for immune modulation Grant US-11471531-B2 United States of America 18 Oct 2022
Selectively altering microbiota for immune modulation Grant US-11471530-B2 United States of America 18 Oct 2022
Treating and preventing microbial infections Grant US-11421227-B2 United States of America 23 Aug 2022
Altering microbial populations and modifying microbiota Grant US-11400110-B2 United States of America 02 Aug 2022
Superagonists, partial agonists and antagonists of interleukin-2 Grant US-11384131-B2 United States of America 12 Jul 2022
Selectively altering microbiota for immune modulation Grant US-11351252-B2 United States of America 07 Jun 2022
COMBINATION THERAPY OF PD-1 AXIS BINDING ANTAGONISTS AND LRRK2 INHITIBORS Application WO-2022084210-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
Methods for treating cancer with bispecific anti-CD3xMUC16 antibodies and anti-PD-1… Grant US-11254752-B2 United States of America 22 Feb 2022
IL-15/IL-15RA HETERODIMERIC FC FUSION PROTEINS AND USES THEREOF Application US-20220040264-A1 United States of America 10 Feb 2022
ENHANCING T-CELL FUNCTION AND TREATING A T-CELL DYSFUNCTIONAL DISORDER WITH A COMBINATION… Application EP-3716963-A4 European Patent Office 11 Aug 2021
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3 IN COMBINATION WITH 4-1… Application WO-2020257604-A1 World Intellectual Property Organisation (WIPO) 24 Dec 2020
IL-15/IL-15Ralpha based conjugates purification method Grant US-10808022-B2 United States of America 20 Oct 2020
COMBINATIONS OF IADADEMSTAT FOR CANCER THERAPY Application WO-2020193631-A1 World Intellectual Property Organisation (WIPO) 01 Oct 2020
Reducing tumor burden by administering CCR1 antagonists in combination with PD-1… Grant US-10568870-B2 United States of America 25 Feb 2020
REDUCING TUMOR BURDEN BY ADMINISTERING CCR1 ANTAGONISTS IN COMBINATION WITH PD-1… Application EP-3439653-A4 European Patent Office 04 Dec 2019
COMBINED TREATMENT WITH NETRIN-1 INTERFERING DRUG AND IMMUNE CHECKPOINT INHIBITORS DRUGS Application US-20190315852-A1 United States of America 17 Oct 2019
Anti-human PD-1 humanized monoclonal antibody and application Application JP-2019514355-A Japan 06 Jun 2019
Anti-human PD-L1 humanized monoclonal antibody and application Application JP-2019514853-A Japan 06 Jun 2019